Live feed07:30:00·1940dPRReleasevia QuantisnowLeading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed MergerByQuantisnow·Wall Street's wire, on your screen.EIDX· Eidos Therapeutics, Inc.BBIO· BridgeBio Pharma Inc.Health CareOriginal source
